Latest Alzheimer's disease Stories

Elderly patients who receive anesthesia are no more likely to develop long-term dementia or Alzheimer's disease than other seniors, according to new Mayo Clinic research. The study analyzed thousands of patients using the Rochester Epidemiology Project -- which allows researchers access to medical records of nearly all residents of Olmsted County, Minn. -- and found that receiving general anesthesia for procedures after age 45 is not a risk factor for developing dementia. The findings were...

Brett Smith for redOrbit.com - Your Universe Online Researchers from Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO) are reporting significant progress in developing a blood test that can predict the onset of Alzheimer’s in an individual. According to their report in the journal Molecular Psychiatry, the researchers said they have identified several biomarkers that are associated with the toxic build-up of beta amyloid, a brain signaling protein....

CEOi Spotlights Alzheimer's at 2013 Milken Global Conference, Calls for New Global Framework to Stop Alzheimer's Disease by 2025 LOS ANGELES, May 1, 2013 /PRNewswire-USNewswire/ -- The Global CEO Initiative on Alzheimer's Disease (CEOi), a new business consortium leading the fight against Alzheimer's, today announced its commitment to a new global framework to combat Alzheimer's disease. The CEOi's goal is to create a clear pathway to diagnose, prevent and treat Alzheimer's by 2025,...

FORT LAUDERDALE, Fla., May 1, 2013 /PRNewswire/ -- Scientists have linked chronic inflammatory events in the brain with the onset and progression of Alzheimer's disease. Now, South Florida residents who have mild or moderate Alzheimer's disease can participate in a study that measures the effects of a novel medication therapy to reduce inflammation and a nutritional supplement program. (Logo: http://photos.prnewswire.com/prnh/20120223/FL58611LOGO-b ) The Life Extension...

Over 500 technology innovators, philanthropists, government officials, healthcare executives, clinicians and members of the media will gather at the Mandarin Oriental Hotel, in Washington, DC to focus on the future of women’s health where technology facilitates patient interaction, and philanthropy and industry partner to accelerate technology breakthroughs. Washington, DC (PRWEB) April 28, 2013 Tonight, the Society for Women’s Health Research will host IMAGINE IT, their Annual Gala...

This book teaches how to train a dog to partner with a caregiver to help control patient wandering to be featured at Book Expo America 2013 in New York, May 30 - June 1. FRONT ROYAL, Va., April 26, 2013 /PRNewswire/ -- Caregivers of Alzheimer's patients living at home are exhausted; they need help. That help is here in the form of a loving, specially trained dog that has learned to watch over its patient, to identify wandering, to self-start and alert the caregiver, and then lead...

redOrbit Staff & Wire Reports - Your Universe Online New research published Thursday in the journal Neuron sheds new light on the molecular causes of Alzheimer’s disease, while also revealing a potential new therapy which could help prevent cognitive decline and brain damage during the early stages of the neurodegenerative disorder. The study focuses on a variant of a gene known as CD33, which typically contributes to Alzheimer’s disease by inhibiting the ability of a body’s...

A multicenter study led by scientists at the University of Pittsburgh School of Medicine shows that mild traumatic brain injury after blast exposure produces inflammation, oxidative stress and gene activation patterns akin to disorders of memory processing such as Alzheimer's disease. Their findings were recently reported in the online version of the Journal of Neurotrauma. Blast-induced traumatic brain injury (TBI) has become an important issue in combat casualty care, said senior...

Previous Research Showed Bexarotene May Have Impact on Biomarkers in the Human Brain NEW YORK, April 24, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and BrightFocus Foundation today announced a funding collaboration that will support a Phase I human clinical trial to evaluate the cancer drug bexarotene as a treatment for Alzheimer's disease. Through this partnership, the organizations are working to address a gap in funding that exists for these...

HARRISBURG, Pa., April 23, 2013 /PRNewswire-USNewswire/ -- Governor Tom Corbett today announced the appointment of 17 members to the Pennsylvania Alzheimer's Disease State Planning Committee. Established through Executive Order by Corbett on Feb. 7, the committee will work to create a state plan to address the growing Alzheimer's disease crisis in Pennsylvania. "Caring for and protecting our older Pennsylvanians is a top priority of my administration," Corbett said. "With our population...